Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antigen processing and immune regulation in the response to tumours
Emma Reeves, Edward James
Immunology (2016) Vol. 150, Iss. 1, pp. 16-24
Open Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

A guide to antigen processing and presentation
Novalia Pishesha, Thibault J. Harmand, Hidde L. Ploegh
Nature reviews. Immunology (2022) Vol. 22, Iss. 12, pp. 751-764
Closed Access | Times Cited: 435
Oncolytic viruses as engineering platforms for combination immunotherapy
Kwame Twumasi‐Boateng, Jessica L. Pettigrew, Young Kwok, et al.
Nature reviews. Cancer (2018) Vol. 18, Iss. 7, pp. 419-432
Closed Access | Times Cited: 358
Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
Anping Li, Ming Yi, Shuang Qin, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 288
Improving radiotherapy in cancer treatment: Promises and challenges
Helen H.W. Chen, Macus Tien Kuo
Oncotarget (2017) Vol. 8, Iss. 37, pp. 62742-62758
Open Access | Times Cited: 281
Mechanisms of Cancer Resistance to Immunotherapy
Rilan Bai, Naifei Chen, Lingyu Li, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 261
Combining DNA damaging therapeutics with immunotherapy: more haste, less speed
Jessica Brown, Raghav Sundar, Juanita Lopez
British Journal of Cancer (2017) Vol. 118, Iss. 3, pp. 312-324
Open Access | Times Cited: 214
Hair follicle immune privilege and its collapse in alopecia areata
Marta Bertolini, Kevin J. McElwee, Amos Gilhar, et al.
Experimental Dermatology (2020) Vol. 29, Iss. 8, pp. 703-725
Open Access | Times Cited: 209
Bispecific T-cell engagers: Towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their efficacy and safety
Diego Ellerman
Methods (2018) Vol. 154, pp. 102-117
Open Access | Times Cited: 171
Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer
Anita K. Mehta, Sapana Kadel, Madeline G Townsend, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 156
Cancer immune escape: the role of antigen presentation machinery
Anoop Kallingal, Mateusz Olszewski, Natalia Maciejewska, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 8131-8141
Open Access | Times Cited: 63
Involvement of inflammasomes in tumor microenvironment and tumor therapies
Ziqi Zhang, Xue Li, Yang Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 46
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 44
The crosstalk of CD8+ T cells and ferroptosis in cancer
Zhengjun Lin, Songzhu Zou, Kunming Wen
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 25
Role of the immunosuppressive microenvironment in immunotherapy
Garth W. Tormoen, Marka R. Crittenden, Michael J. Gough
Advances in Radiation Oncology (2018) Vol. 3, Iss. 4, pp. 520-526
Open Access | Times Cited: 150
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells
Marco Tucci, Anna Passarelli, Francesco Mannavola, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 117
Molecular pathogenic pathways in extranodal NK/T cell lymphoma
Sanjay De Mel, Susan Swee-Shan Hue, Anand D. Jeyasekharan, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 115
Network Pharmacology to Unveil the Biological Basis of Health-Strengthening Herbal Medicine in Cancer Treatment
Jiahui Zheng, Min Wu, Haiyan Wang, et al.
Cancers (2018) Vol. 10, Iss. 11, pp. 461-461
Open Access | Times Cited: 103
Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma
Jun S. Wei, Igor B. Kuznetsov, Shile Zhang, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 22, pp. 5673-5684
Open Access | Times Cited: 102
Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer
Xiao Jin, Lu Dai, Yilan Ma, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 100
Role of cell surface proteoglycans in cancer immunotherapy
Nancy Adriana Espinoza‐Sánchez, Martin Götte
Seminars in Cancer Biology (2019) Vol. 62, pp. 48-67
Closed Access | Times Cited: 85
The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses
Tania Løve Aaes, Peter Vandenabeele
Cell Death and Differentiation (2020) Vol. 28, Iss. 3, pp. 843-860
Open Access | Times Cited: 84
Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
Qinjun Chen, Tao Sun, Chen Jiang
Nano-Micro Letters (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 76
The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses
Diana Campillo-Davó, Donovan Flumens, Eva Lion
Cells (2020) Vol. 9, Iss. 7, pp. 1720-1720
Open Access | Times Cited: 72
Tumor Immunity and Immunotherapy for HPV-Related Cancers
A. Shamseddine, Bharat Burman, Nancy Y. Lee, et al.
Cancer Discovery (2021) Vol. 11, Iss. 8, pp. 1896-1912
Open Access | Times Cited: 70
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer
Uta M. Demel, Marlitt Böger, Schayan Yousefian, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 9
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top